Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria

K. Gianmoena, N. Gasparoni, A. Jashari, P. Gabrys, K. Grgas, A. Ghallab, K. Nordstrom, G. Gasparoni, J. Reinders, K. Edlund, P. Godoy, A. Schriewer, H. Hayen, C.A. Hudert, G. Damm, D. Seehofer, T.S. Weiss, P. Boor, H.J. Anders, M. MotrapuP. Jansen, T.S. Schiergens, M. Falk-Paulsen, P. Rosenstiel, C. Lisowski, E. Salido, R. Marchan, J. Walter, J.G. Hengstler, C. Cadenas*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Web of Science)
Original languageEnglish
Article number109526
Number of pages27
JournalCell Reports
Volume36
Issue number8
DOIs
Publication statusPublished - 24 Aug 2021

Keywords

  • FATTY LIVER-DISEASE
  • CHRONIC KIDNEY-DISEASE
  • GENE-EXPRESSION
  • CARDIOVASCULAR-DISEASE
  • PRIMARY HEPATOCYTES
  • GLYCOLATE OXIDASE
  • FACTOR-BINDING
  • MOUSE MODELS
  • WEB-SERVER
  • IN-VITRO

Cite this